HOME | OUR COMPANY | PRODUCT PORTFOLIO | PRESS ROOM| INVESTORS | CAREERS | CONTACT US
SITE MAP | TERMS OF USE | PRIVACY POLICY

emergent biosolutions logo
Home Page
Our Company
Technologies
spi-VEC TM
MVAtor TM Executive Management
Board of Directors
Business Development
Business Development

Our Company

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body's immune system to prevent or treat disease. Emergent's marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax disease. Emergent's product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia.

OUR COMPANY Product Portfolio Press Room INVESTORS CAREERS CONTACT US